Trails Edge Biotechnology USA Fund, LP
Trails Edge Biotechnology USA Fund, LP is a hedge fund based in Atlanta, Georgia. According to its most recent Form D, filed Jun 25, 2026, the fund has sold $205,966,000 of interests to 22 investors since its first sale in Jul 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. Related persons named in the filing include Trails Edge Biotechnology Fund GP, LP; Trails Edge Capital Partners, LP; Ortav Yehudai.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $205,966,000Cumulative sales reported on Form D
- Investors
- 22
- First sale
- Jul 1, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Other exemption
- Key people and entities
- Trails Edge Biotechnology Fund GP, LP; Trails Edge Capital Partners, LP; Ortav Yehudai
- Latest Form D
- Jun 25, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Trails Edge Biotechnology USA Fund, LP
What is the minimum investment for Trails Edge Biotechnology USA Fund, LP?
Trails Edge Biotechnology USA Fund, LP's latest Form D, filed Jun 25, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Trails Edge Biotechnology USA Fund, LP?
Trails Edge Biotechnology USA Fund, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7).
How much has Trails Edge Biotechnology USA Fund, LP raised?
Trails Edge Biotechnology USA Fund, LP reports $205,966,000 sold from 22 investors on its Form D filed Jun 25, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Trails Edge Biotechnology USA Fund, LP based?
Trails Edge Biotechnology USA Fund, LP is based in Atlanta, Georgia and is managed by Trails Edge Capital Partners, LP.
When did Trails Edge Biotechnology USA Fund, LP launch?
Trails Edge Biotechnology USA Fund, LP reports its first sale in Jul 2025.
Size compared with every hedge fund
Raised more than 86% of the 144 hedge funds based in Georgia, and more than 70% of all 10,308 that report sales.